laparoscopic cholecystectomy.
Conditions
Interventions
Intervention 1: Intervention group: (Group I) 30 ml of 0.2% ropivacaine (made by Multeni company) enters the peritoneal space through the trocar. Intervention 2: Intervention group:2: (Group T) after
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Obtaining informed consent Patient aged 18 to 65 years with ASA class I & II who is a candidate for laparoscopic cholecystectomy
Exclusion criteria
Exclusion criteria: Conductive heart diseases that prevent the use of local anesthetics. Patients taking painkillers for other chronic pain Patients with a history of drug use or alcoholism BMI> 35 Patients who are unable to express pain score for any psychological reason Previous abdominal surgery Allergy to any local anesthetic
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post operative pain. Timepoint: The patient's pain is measured at 0, 2, 4, 8, 12, 18 and 24. Method of measurement: The patient's pain is measured, and recorded by the recovery staff based on the VAS criteria or scoring of pain sensation and by the ward staff after discharge from the recovery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactparia dinparvar
Shiraz University of Medical Sciences
Outcome results
None listed